CZ286482B6 - Medicament for treating casual infections in mammals including human beings - Google Patents
Medicament for treating casual infections in mammals including human beings Download PDFInfo
- Publication number
- CZ286482B6 CZ286482B6 CZ1997209A CZ20997A CZ286482B6 CZ 286482 B6 CZ286482 B6 CZ 286482B6 CZ 1997209 A CZ1997209 A CZ 1997209A CZ 20997 A CZ20997 A CZ 20997A CZ 286482 B6 CZ286482 B6 CZ 286482B6
- Authority
- CZ
- Czechia
- Prior art keywords
- medicament
- infections
- formula
- compound
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9414902A GB9414902D0 (en) | 1994-07-23 | 1994-07-23 | Methods |
| PCT/US1995/008915 WO1996003126A1 (en) | 1994-07-23 | 1995-07-14 | Method of treating opportunistic infections with azaspiranes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ20997A3 CZ20997A3 (en) | 1997-10-15 |
| CZ286482B6 true CZ286482B6 (en) | 2000-04-12 |
Family
ID=10758802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ1997209A CZ286482B6 (en) | 1994-07-23 | 1995-07-14 | Medicament for treating casual infections in mammals including human beings |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0804201A4 (hu) |
| JP (1) | JPH10503202A (hu) |
| KR (1) | KR970704446A (hu) |
| CN (1) | CN1157564A (hu) |
| AU (1) | AU684384B2 (hu) |
| BR (1) | BR9508332A (hu) |
| CA (1) | CA2195778A1 (hu) |
| CZ (1) | CZ286482B6 (hu) |
| GB (1) | GB9414902D0 (hu) |
| HU (1) | HUT77379A (hu) |
| MX (1) | MX9700626A (hu) |
| NO (1) | NO310096B1 (hu) |
| NZ (1) | NZ290974A (hu) |
| WO (1) | WO1996003126A1 (hu) |
| ZA (1) | ZA956098B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9601909A (pt) * | 1995-07-13 | 1999-10-13 | Smithkline Beecham Corp | N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4963557A (en) * | 1987-09-28 | 1990-10-16 | Smithkline Beecham Corporation | Immunomodulatory azaspiranes |
| ZA921120B (en) * | 1991-02-19 | 1993-01-27 | Smithkline Beecham Corp | Cytokine inhibitors |
| PT100566B (pt) * | 1991-06-07 | 1999-06-30 | Smithkline Beecham Corp | Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso |
-
1994
- 1994-07-23 GB GB9414902A patent/GB9414902D0/en active Pending
-
1995
- 1995-07-14 MX MX9700626A patent/MX9700626A/es not_active IP Right Cessation
- 1995-07-14 BR BR9508332A patent/BR9508332A/pt not_active Application Discontinuation
- 1995-07-14 HU HU9700201A patent/HUT77379A/hu unknown
- 1995-07-14 CN CN95195052A patent/CN1157564A/zh active Pending
- 1995-07-14 KR KR1019970700433A patent/KR970704446A/ko not_active Application Discontinuation
- 1995-07-14 AU AU31909/95A patent/AU684384B2/en not_active Ceased
- 1995-07-14 JP JP8505798A patent/JPH10503202A/ja active Pending
- 1995-07-14 CA CA002195778A patent/CA2195778A1/en not_active Abandoned
- 1995-07-14 EP EP95928072A patent/EP0804201A4/en not_active Withdrawn
- 1995-07-14 CZ CZ1997209A patent/CZ286482B6/cs not_active IP Right Cessation
- 1995-07-14 WO PCT/US1995/008915 patent/WO1996003126A1/en not_active Application Discontinuation
- 1995-07-14 NZ NZ290974A patent/NZ290974A/xx unknown
- 1995-07-21 ZA ZA956098A patent/ZA956098B/xx unknown
-
1997
- 1997-01-22 NO NO19970284A patent/NO310096B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MX9700626A (es) | 1997-05-31 |
| BR9508332A (pt) | 1997-11-04 |
| ZA956098B (en) | 1996-05-23 |
| HUT77379A (hu) | 1998-04-28 |
| GB9414902D0 (en) | 1994-09-14 |
| NO310096B1 (no) | 2001-05-21 |
| CZ20997A3 (en) | 1997-10-15 |
| JPH10503202A (ja) | 1998-03-24 |
| CN1157564A (zh) | 1997-08-20 |
| NO970284L (no) | 1997-03-19 |
| KR970704446A (ko) | 1997-09-06 |
| NO970284D0 (no) | 1997-01-22 |
| EP0804201A1 (en) | 1997-11-05 |
| WO1996003126A1 (en) | 1996-02-08 |
| HU9700201D0 (en) | 1997-04-28 |
| NZ290974A (en) | 1999-08-30 |
| AU684384B2 (en) | 1997-12-11 |
| AU3190995A (en) | 1996-02-22 |
| EP0804201A4 (en) | 2000-04-26 |
| CA2195778A1 (en) | 1996-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0385517B1 (en) | Medicaments for the treatment of emesis | |
| RU2355399C2 (ru) | Противоопухолевые композиции, содержащие производное рапамицина и ингибитор ароматазы | |
| NO334612B1 (no) | Stabilisering av makrolider | |
| JPH0349893B2 (hu) | ||
| JPH05262651A (ja) | 向精神薬の安定化溶液 | |
| CZ284363B6 (cs) | Použití protikřečových činidel k přípravě léčiv určených k léčení Parkinsonovy choroby a Parkinsonových syndromů | |
| CZ284423B6 (cs) | Použití lamotriginu pro přípravu léčiv určených k léčení neuronální degenerace způsobené AIDS | |
| PL183040B1 (pl) | Kompozycja farmaceutyczna nierozpuszczalnych w wodzie kamptotecyn | |
| EP0542860B1 (en) | Immunosuppressive compositions | |
| CZ286482B6 (en) | Medicament for treating casual infections in mammals including human beings | |
| WO2000007605A1 (fr) | Utilisation de derives de la camptothecine, avec une toxicite gastro-intestinale reduite | |
| US5786376A (en) | Methods of treating opportunistic infections with azaspiranes | |
| CA2946151C (en) | Stable solid immunosuppressor composition | |
| KR20060134232A (ko) | 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물 | |
| US20220339175A1 (en) | Application of Stachyose in Preparation of Drug for Treating Castration-Resistant Prostate Cancer | |
| CZ281691B6 (cs) | Farmaceutický prostředek proti vysokému krevnímu tlaku | |
| JPH09500646A (ja) | アザスピランによるｈｉｖの治療法 | |
| CA2128535A1 (en) | A method for delaying hiv induced aids by administration of substituted azaperane compounds | |
| AU710542B2 (en) | Use of substituted azaspirane in the treatment of asthma | |
| US20040248926A1 (en) | Preventive or remedy for pruritus | |
| KR20230157119A (ko) | B형 간염 예방 또는 치료용 약학 조성물 | |
| US20010014676A1 (en) | Immunosuppressive compositions | |
| JP2005520806A (ja) | がん治療を改善する併用療法におけるキナゾリノン化合物 | |
| EP3463374A1 (en) | A long acting pharmaceutical composition of protease inhibitor | |
| TW201740929A (zh) | 蛋白酶抑製劑之長效醫藥組合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF00 | In force as of 2000-06-30 in czech republic | ||
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20020714 |